Pipeline Setbacks for Big Pharma: AZ, Sanofi, Novartis Take Hits

Big Pharma saw several pipeline setbacks Tuesday, with AstraZeneca, Sanofi and Novartis announcing trial failures, a study termination, and the end of a drug development program.
Drug Industry Daily